Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The First Pituitary Proteome Landscape From Matched Anterior and Posterior Lobes for a Better Understanding of the Pituitary Gland. | Mol Cell Proteomics | 2023 | 36470533 | PubTator, text mining | PubMed |
| Research progress on the intrinsic non-immune function of PD-L1 in tumors (Review). | Oncol Lett | 2023 | 36466997 | PubTator, text mining | PubMed |
| TYRO3 agonist as therapy for glomerular disease. | JCI Insight | 2023 | 36454644 | PubTator, text mining | PubMed |
| Single-cell RNA-Seq analysis of diabetic wound macrophages in STZ-induced mice. | J Cell Commun Signal | 2023 | 36445632 | PubTator, text mining | PubMed |
| Mitochondria as disease-relevant organelles in rheumatoid arthritis. | Clin Exp Immunol | 2023 | 36420636 | PubTator, text mining | PubMed |
| Guillain-Barré Syndrome Following Zika Virus Infection Is Associated With a Diverse Spectrum of Peripheral Nerve Reactive Antibodies. | Neurol Neuroimmunol Neuroinflamm | 2023 | 36411078 | PubTator, text mining | PubMed |
| GALNT2 promotes invasiveness of colorectal cancer cells partly through AXL. | Mol Oncol | 2023 | 36409270 | PubTator, text mining | PubMed |
| Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER. | Mol Cancer Ther | 2023 | 36399631 | PubTator, text mining | PubMed |
| The prognostic role of p53 and its correlation with CDK9 in urothelial carcinoma. | Clin Transl Oncol | 2023 | 36374405 | PubTator, text mining | PubMed |
| Proteomics reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients. | Biochim Biophys Acta Mol Basis Dis | 2023 | 36328146 | PubTator, text mining | PubMed |
| Cooperative induction of receptor tyrosine kinases contributes to adaptive MAPK drug resistance in melanoma through the PI3K pathway. | Cancer Rep (Hoboken) | 2023 | 36251678 | PubTator, text mining | PubMed |
| Association of Glial Activation and α-Synuclein Pathology in Parkinson's Disease. | Neurosci Bull | 2023 | 36229715 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Molecular Mechanisms of ZIKV-Induced Teratogenesis: A Systematic Review of Studies in Animal Models. | Mol Neurobiol | 2023 | 36215025 | PubTator, text mining | PubMed |
| LncRNA SNHG3 enhances BMI1 mRNA stability by binding and regulating c-MYC: Implications for the carcinogenic role of SNHG3 in bladder cancer. | Cancer Med | 2023 | 36208024 | PubTator, text mining | PubMed |
| Beyond direct killing-novel cellular immunotherapeutic strategies to reshape the tumor microenvironment. | Semin Immunopathol | 2023 | 36167831 | PubTator, text mining | PubMed |
| Retraction notice to "LncRNA GAS6-AS1 facilitates the progression of breast cancer by targeting the miR-324-3p/SETD1A axis to activate the PI3K/AKT pathway" [Eur. J. Cell Biol. 99 (2020) 151124]. | Eur J Cell Biol | 2023 | 36127170 | PubTator, text mining | PubMed |
| The Role of Macrophages and Alveolar Epithelial Cells in the Development of ARDS. | Inflammation | 2023 | 36048270 | PubTator, text mining | PubMed |
| GAS6 From CD200+ Adipose-Derived Stem Cells Mitigates Colonic Inflammation in a Macrophage-Dependent Manner. | J Crohns Colitis | 2023 | 36006655 | PubTator, text mining | PubMed |
| Roles of Vitamin-K-dependent Factors Protein S and GAS6 With TAM Receptors and HMGB1 in Pediatric COVID-19 Disease. | J Pediatr Hematol Oncol | 2023 | 35973116 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=34